Genus Capital Management’s Bruker BRKR Stock Holding History

Genus Capital Management’s Portfolio BRKR Stock Details BRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,300	Closed	-$968K	–	224
2024 Q1	$968K	Buy	+10,300	New	+$829K	0.13%	142
2023 Q4	–	Sell	-10,300	Closed	-$660K	–	222
2023 Q3	$642K	Hold	10,300	–	–	0.1%	140
2023 Q2	$761K	Buy	+10,300	New	+$785K	0.11%	147

Other funds holding BRKR

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCA

Pallas Capital Advisors Braintree, Massachusetts $2.66B AUM 22.31% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return

Genus Capital Management's BRKR Position: Q2 2024 in Review

Genus Capital Management sold out of Bruker (BRKR) in Q2 2024, closing a stake of 10,300 shares — an estimated $968K sold.

Genus Capital Management first reported a position in BRKR in Q2 2023 and held it in 3 quarters. The position peaked at $968K in Q1 2024. 365 funds tracked by Wall St. Rank hold BRKR as of Q2 2024.

Genus Capital Management reported no remaining Bruker position as of Q2 2024 after selling out during the quarter.
Genus Capital Management sold 10,300 Bruker shares in Q2 2024, an estimated $968K.
Genus Capital Management first reported a position in Bruker in Q2 2023 and held it in 3 quarters.
Genus Capital Management's Bruker position peaked at $968K in Q1 2024.
365 funds tracked by Wall St. Rank held Bruker as of Q2 2024.

Based on Genus Capital Management's 13F filing for Q2 2024, filed 9 Aug 2024.